Reactivate the immune system by inhibiting the checkpoint blockade!
In Vitro Technologies expands your Immune Checkpoint Blockade research capabilities
We’ve got you covered to to target multiple cancers in your Immune Checkpoint Blockade research with:
- The most dependable selection of blocking antibodies
- Potential drug targets with a wide selection of highly bioactive immunomodulatory proteins
- B cells, Cytotoxic T cells, and natural killer cells to measure activation by antibodies, adjuvants, or other immunomodulatory substances
Let In Vitro Technologies share their expertise to facilitate more effective immune checkpoint blockade strategies
Supporting Literature
ATCC Primary Immunology Cells
ATCC Tumor Cell Panels Brochures
R&D System Immunology Brochure
ACEA Hallmarks of Cancer Brochure
ATCC Immunological Research Tools
R&D Systems Cancer Immunotherapy Research
ACEA What is Cancer Immunotherapy?
Looking for more information on Cancer Immunotherapy?
- For more information on In Vitro’s work flow in cancer immunotherapy, click here.
- For more from In Vitro Technologies on “Transform the immune system”, click here.
- For more on Immune Modulation – novel molecules as potential cancer immunotherapy strategy, please contact us.
Launched in July 2016 an international consortium of researchers is looking to revolutionise 
